Related Experiment Video

Updated: May 16, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Statins and the elderly: recent evidence and current indications

Gabriele Giacomo Schiattarella1, Cinzia Perrino, Fabio Magliulo

  • 1Department of Clinical Medicine and Cardiovascular and Immunology Sciences, University of Naples Federico II, via Pansini 5, 80131 Napoli, Italy.

Aging Clinical and Experimental Research
|November 20, 2012
PubMed

Insights

Statin use in adults over 80 for cardiovascular disease (CVD) prevention lacks extensive evidence. Clinical judgment is crucial due to limited data on benefits and potential adverse effects in this elderly population.

Area of Science:

  • Gerontology
  • Cardiology
  • Pharmacology

Background:

  • Cardiovascular disease (CVD) remains a leading cause of death, particularly in aging populations.
  • While statins benefit middle-aged adults, evidence for the elderly, especially those over 80, is limited.
  • Increased prevalence of CVD in older adults is partly due to population aging, despite prevention improvements.

Purpose of the Study:

  • To review current evidence on statin therapy for cardiovascular disease (CVD) in individuals aged 80 and over.
  • To examine the benefits and risks of statins in primary and secondary prevention for the elderly.
  • To discuss statins' potential effects on senile dementia and cancer risk.

Main Methods:

  • Review of randomized clinical trials (RCTs) concerning statin use in the elderly.
  • Analysis of community and post-approval data relevant to CVD management in older adults.
  • Synthesis of evidence on statin efficacy and safety in the 80+ population.

Main Results:

  • Limited evidence exists on the overall benefit of initiating statin therapy in adults aged 80 and over.
  • Adverse effects and drug interactions with statins may be more problematic in the elderly.
  • Data on statins' effects on senile dementia and cancer in this age group are also discussed.

Conclusions:

  • Clinical judgment is essential when deciding on statin therapy for individuals aged 80 and over due to insufficient evidence.
  • Further research is needed to clarify the risks and benefits of statins in very elderly populations.
  • The review highlights the need for individualized treatment decisions in geriatric CVD management.

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...